Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + sodium lactate + calcium chloride + magnesium chloride + dextrose
- Development stage
- Approved
- Lead developer
- Vanttive
- Modality
- Small Molecules
- Administration
- Intraperitoneal
01
Overview
A sterile **peritoneal dialysis solution** containing sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose for **intraperitoneal** administration. It was developed by **Baxter** and is currently marketed in the U.S. by **Vantive** under the **DIANEAL PD-2** and **DIANEAL Low Calcium** brands. The solution functions as a **small-molecule electrolyte and carbohydrate dialysate**: dextrose provides the osmotic gradient that drives ultrafiltration across the peritoneal membrane, while sodium, calcium, magnesium, chloride, and lactate help maintain electrolyte and acid-base balance during dialysis. It is indicated for the management of **acute or chronic renal failure** and is used in peritoneal dialysis, including CAPD, when dialysis support is required.
- Brand names
- DIANEAL PD-2DIANEAL Low Calcium
- Other names
- sodium chloride + sodium lactate + calcium chloride + magnesium chloride + dextroseDIANEAL PD-2 WITH DEXTROSEDIANEAL LOW CALCIUM WITH DEXTROSEDIANEAL peritoneal dialysis solution
Beyond the preview
Go deeper on sodium chloride + sodium lactate + calcium chloride + magnesium chloride + dextrose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride + sodium lactate + calcium chloride + magnesium chloride + dextrose.